Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT02780167

Public ClinicalTrials.gov record NCT02780167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL, MULTICENTER, DOSE-RANGING, STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-04965842 IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Study identification

NCT ID
NCT02780167
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
269 participants

Conditions and interventions

Interventions

  • PF-04965842 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2016
Primary completion
Feb 28, 2017
Completion
Mar 31, 2017
Last update posted
May 1, 2019

2016 – 2017

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209
California Dermatology & Clinical Research Institute Encinitas California 92024
Huntington Medical Foundation Pasadena California 91105
Peninsula Research Associates, Inc. Rolling Hills Estates California 90274
Emil A. Tanghetti MD dba Center for Dermatology and Laser Surgery Sacramento California 95819
TCR Medical Corporation San Diego California 92123
Clinical Science Institute Santa Monica California 90404
University of Connecticut Health Center (UConn Health) Farmington Connecticut 06032
Olympian Clinical Research Clearwater Florida 33756
North Florida Dermatology Associates, PA Jacksonville Florida 32204
Park Avenue Dermatology Administration Annex Orange Park Florida 32073
Park Avenue Dermatology Orange Park Florida 32073
Leavitt Medical Associates of Florida d/b/a Ameriderm Research Ormond Beach Florida 32174
Forward Clinical Trials, Inc. Tampa Florida 33624
MedaPhase, Inc. Newnan Georgia 30263
Dundee Dermatology West Dundee Illinois 60118
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Dawes Fretzin Dermatology Group, LLC Indianapolis Indiana 46256
The Indiana Clinical Trials Center Plainfield Indiana 46168
DS Research Louisville Kentucky 40241
Shondra L Smith, MD Dermatology & Advanced Aesthetics Lake Charles Louisiana 70605
Somerset Skin Centre Troy Michigan 48084
MediSearch Clinical Trials Saint Joseph Missouri 64506
Clinical Research Consortium Las Vegas Nevada 89119
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520
The Dermatology Group, P.C Verona New Jersey 07044
Forest Hills Dermatology Group Forest Hills New York 11375
Sadick Research Group New York New York 10075
Vital Prospects Clinical Research Institute, P.C Tulsa Oklahoma 74136
DermDox Centers for Dermatology Hazleton Pennsylvania 18201
UPMC Department of Dermatology Pittsburgh Pennsylvania 15213
Clinical Partners, LLC Johnston Rhode Island 02919
Health Concepts Rapid City South Dakota 57702
Bellaire Dermatology Associates Bellaire Texas 77401
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Virginia Clinical Research,Inc Norfolk Virginia 23502
West End Dermatology Associates Richmond Virginia 23233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02780167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02780167 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →